About
Vision
Origins
Team
Science
Rewriting RNA
Ascidian's Approach
Publications & Presentations
Pipeline
Programs
News
Press Releases
In the News
Careers
Ascidian Life
Opportunities
Get in Touch
News
Press Releases
Press Releases
In the News
May 9, 2023
Ascidian Therapeutics to Present New Data From Its Lead Program Targeting ABCA4 Retinopathies at the ASGCT 2023 Annual Meeting
Read More
April 18, 2023
Ascidian Therapeutics to Present Data From Its Lead Program Targeting ABCA4 Retinopathies at the Retinal Cell and Gene Therapy Innovation Summit and ARVO 2023 Annual Meeting
Read More
April 11, 2023
Ascidian Therapeutics Announces Three Key Development Team Appointments as It Advances Its Lead Program Toward the Clinic
Read More
March 20, 2023
Ascidian Therapeutics Appoints Jay A. Barth, M.D., as Chief Medical Officer
Read More
January 4, 2023
Ascidian Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
Read More
October 12, 2022
Ascidian Therapeutics Launches to Rewrite RNA
Read More